Earlier diagnosis and genetic testing are not only critical for increasing positive outcomes for patients with cancer, but are also facilitating a greater understanding of the mechanisms behind cancers. Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care with the goal of improving quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its science and technology to create new modalities and medicines for people with cancer, cardiovascular, and other diseases with high unmet medical needs.
In this video, find out how Daiichi Sankyo scientists are uncovering new ways to address needs in cancer. For more information, please visit www.daiichi-sankyo.eu.”
Daiichi Sankyo has commissioned and funded the production and distribution of this video.
